Low Dose Edoxaban in Elderly Patients With AF and a History of Stroke
A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 300 participants.
Also called NCT06900725
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose prevention
- Phase
- Phase 2/3
- Enrolled
- 300 participants
- Registry
-
NCT06900725
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Taiwan
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT06900725. Randomized; no masking; primary purpose prevention. Start 2025-04-01 (anticipated); primary completion 2030-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Low Dose Edoxaban in Elderly Patients With AF and a History of Stroke
- Acronym
- LEAVE-Stroke
- Condition
- Elderly
- Condition
- Atrial Fibrillation (AF)
- Condition
- Ischemic Stroke
- Intervention (Drug)
- edoxaban
- Intervention (Drug)
- Edoxaban 30 mg
- Lead sponsor
- National Taiwan University Hospital
- Collaborator
- National Taiwan University Hospital, Yun-Lin Branch
- Collaborator
- National Taiwan University Hospital Hsin-Chu Branch
Record details
- Record id
cardio:ct-nct06900725- Content hash
945d0f98c2744f1725d9cb87a3f336c4fba8a5517cc7192d3bd4a1d1f8772dc0